Clinical Trials Directory

Trials / Completed

CompletedNCT04332250

Influence Of Incomplete Revascularization on Long-Term Outcomes After Primary Percutaneous Coronary Intervention (PPCI)

Influence Of Incomplete Revascularization on Long-Term Outcomes After Primary Percutaneous Coronary Intervention (PPCI). A Single Center Real-Life Retrospective Analysis

Status
Completed
Phase
Study type
Observational
Enrollment
3,200 (actual)
Sponsor
Amany Edward Ramzy · Academic / Other
Sex
All
Age
19 Years
Healthy volunteers
Accepted

Summary

evaluate the influence of incomplete revascularization during the index hospitalization on in-hospital and long-term outcomes in STEMI patients undergoing PPCI in Assiut University heart hospital.

Detailed description

* Study groups: Patients will be divided into 2 groups 1. Group I: Complete revascularization was achieved by PPCI. 2. Group II: Complete revascularization was not achieved by PPCI. * In hospital outcomes: All the patients will be reviewed for during hospital admission to record major acute cardiac events (MACE). Only the most serious event of major adverse cardiac events will be used to calculate the cumulative major adverse cardiac events per patient according to the following sequence: (death \> heart failure \> recurrent non-fatal MI \> serious secondary arrhythmia necessitating DC shock\> recurrent or refractory angina. MACE will be reported according to the standard definitions.(Tsai IT, et al.,2017) * Long-term follow-up: The patients will be followed by telephone interviews for all-cause mortality, re-hospitalization by ACS, re-hospitalization by heart failure, planned and unplanned PCI or CABG. Long-term MACE will include: all-cause mortality, re-hospitalization by ACS, re-hospitalization by heart failure, unplanned revascularization. Patients who undergo planned revascularization later on after discharge will be followed till the date of revascularization for actual events and will be censored in Kaplan Meier Survival analysis. These patients will be included in a third group of staged late complete revascularization to be followed for the long-term MACE events starting from the planned revascularization procedure.

Conditions

Timeline

Start date
2016-01-01
Primary completion
2019-12-01
Completion
2019-12-30
First posted
2020-04-02
Last updated
2020-04-03

Source: ClinicalTrials.gov record NCT04332250. Inclusion in this directory is not an endorsement.